Application 087943
- Type
- ANDA
- Sponsor
- AUXILIUM PHARMS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | THEO-24 | THEOPHYLLINE | CAPSULE, EXTENDED RELEASE;ORAL | 200MG | No | No |
| 002 | THEO-24 | THEOPHYLLINE | CAPSULE, EXTENDED RELEASE;ORAL | 100MG | No | No |
| 003 | THEO-24 | THEOPHYLLINE | CAPSULE, EXTENDED RELEASE;ORAL | 300MG | No | No |
| 004 | THEO-24 | THEOPHYLLINE | CAPSULE, EXTENDED RELEASE;ORAL | 400MG | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A087943-001 | THEO-24 | THEOPHYLLINE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | |
| A087943-002 | THEO-24 | THEOPHYLLINE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | ||
| A087943-003 | THEO-24 | THEOPHYLLINE | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | ||
| A087943-004 | THEO-24 | THEOPHYLLINE | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A087943-001 | THEO-24 | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A087943-002 | THEO-24 | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A087943-003 | THEO-24 | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A087943-004 | THEO-24 | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A087943-001 | THEO-24 | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A087943-002 | THEO-24 | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A087943-003 | THEO-24 | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A087943-004 | THEO-24 | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A087943-001 | THEO-24 | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A087943-002 | THEO-24 | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A087943-003 | THEO-24 | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A087943-004 | THEO-24 | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A087943-001 | THEO-24 | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A087943-002 | THEO-24 | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A087943-003 | THEO-24 | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A087943-004 | THEO-24 | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A087943-001 | THEO-24 | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A087943-002 | THEO-24 | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A087943-003 | THEO-24 | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A087943-004 | THEO-24 | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A087943-001 | THEO-24 | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A087943-002 | THEO-24 | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A087943-003 | THEO-24 | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A087943-004 | THEO-24 | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A087943-001 | THEO-24 | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A087943-002 | THEO-24 | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A087943-003 | THEO-24 | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A087943-004 | THEO-24 | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A087943-001 | THEO-24 | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A087943-002 | THEO-24 | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A087943-003 | THEO-24 | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A087943-004 | THEO-24 | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A087943-001 | THEO-24 | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A087943-002 | THEO-24 | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A087943-003 | THEO-24 | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A087943-004 | THEO-24 | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A087943-001 | THEO-24 | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 1983-08-22 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A087943-002 | THEO-24 | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A087943-003 | THEO-24 | 300MG | CAPSULE, EXTENDED RELEASE / ORAL | 1983-08-22 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A087943-004 | THEO-24 | 400MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 1992-02-28 | d06236e962d9… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Theo-24 | THEOPHYLLINE ANHYDROUS | ENDO USA, Inc. | 7a108fa0-c230-475f-be93-6f864b98a410 | 2024-07-08 | Warnings, Adverse reactions | 087943 ANDA087943 52244-200 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 52244-200 | Theo-24 | theophylline anhydrous | Endo Pharmaceuticals, Inc. | ANDA | Current |